p53 Mutation in Nonmelanoma Skin Cancers Occurring in Psoralen Ultraviolet A-Treated Patients: Evide...
p53 Mutation in Nonmelanoma Skin Cancers Occurring in Psoralen Ultraviolet A-Treated Patients: Evidence for Heterogeneity and Field Cancerization
About this item
Full title
Author / Creator
Publisher
Danvers, MA: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Danvers, MA: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
A combination of psoralens and ultraviolet A radiation is widely used to treat psoriasis. Long-term, high-dose exposure to psoralen + ultraviolet A is associated with an increased risk of nonmelanoma skin cancer, particularly squamous cell carcinoma. In this study, we used p53 mutations as a molecular marker to determine the separate contributions...
Alternative Titles
Full title
p53 Mutation in Nonmelanoma Skin Cancers Occurring in Psoralen Ultraviolet A-Treated Patients: Evidence for Heterogeneity and Field Cancerization
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_210373303
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_210373303
Other Identifiers
ISSN
0022-202X
E-ISSN
1523-1747
DOI
10.1046/j.1523-1747.2002.01814.x
